Substitution Groups File
Be Prepared for the Development and Growth of Biosimilars
As a supplemental file to MED-File v2 and other Medi-Span core drug information databases, the Substitution Groups File helps healthcare organizations keep pace with the evolving landscape of biosimilars.
What It Does for Your Business
- Provides information concerning the concepts describing biosimilar drugs and whether they are rated as Interchangeable or Biosimilar
- Allows the user to group biosimilar drugs for reporting purposes and show the relationships between originator and reference drugs
What It Provides
The Substitution Groups File consists of two files that provide the following:
- General information concerning drugs that may be classified into groups according to their Medi-Span Generic Product Identifier (GPI)
- More detailed information including associated NDCs, description, rating type, sub-group number, and the reference concept number
Delivery and Required Solutions
This is a supplemental file that is dependent on the NDCs within Medi-Span core drug files.
Dependent on delivery of your current drug file
Required Companion Solutions
One of the Medi-Span core drug information databases:
- MED-File v2
- Master Drug Database
- Drug Information Bridge
Need more information?
Call us at 855.633.0577 or fill out our online form and we'll have someone contact you!
of customers are satisfied with the quality of Medi-Span data
of customers are likely to renew their Medi-Span data license
Hundreds of customers see 50% or greater increase in productivity with Medi-Span
See why more healthcare businesses are choosing Medi-Span for their drug data:
Speed to Market
Medi-Span implementation support helped save me one month in speed to market and about $10,000 in development costs.
Medi-Span, in my view, beats everyone else. It helps you find twice as many drug errors – errors that would lead to readmission - in half the amount of time.
(Medi-Span) allows us to provide features that our competitors do not have.
As a claims processor, we rely on Medi-Span and its wealth of drug information to forecast and price claims for our clients. Medi-Span is the go-to (application) that is recognized across the industry for (manufacturer-provided) drug information. They have innovative tools and excellent customer service that will go above and beyond to provide the best available solution.
Medi-Span implementation support helped save me one month in speed to market and about $10,000 in development costs.”
Consistent Pricing Data
It is the source for the benchmark prices consistently used in the PBM industry and the tool we use to hold PBMs accountable to their pricing promises to our employers.
Business cannot survive without Medi-Span data.
Only reliable published resource for (manufacturer-provided) AWP. (Medi-Span proprietary) GPI is therapeutic classification system of choice. It is very enabling, as clinical management rules are easily articulated.
Even in an era where data abounds, there is a terrific amount of uncertainty. People want confidence that what they are seeing is (based on) real (manufacturer-provided information) – Medi-Span provides that confidence.
(Medi-Span) allows for consistency across the company, industry and clients.
Timely and Relevant
The Medi-Span database allows our system to have the latest and most current information available. It is especially needed for package information, interaction checking, and clinical printing.
This is a foundational piece that is used throughout the organization in many systems and is often used to connect data from multiple systems.
Who is Clinical Drug Information?
With the move to team-based care, conflicting data can lead to actual conflicts – from disparity in business decisions to confusion in communication. We research, validate, and synthesize content to show the right data to right people at the right time. With content developed in a consistent manner across all platforms and resources, your team receives aligned drug information no matter when or how they access it. This helps:
- Improve communication
- Reduce confusion
- Enhance patient care
Impacting thousands of healthcare organizations - see our storyPlay Video
How can our award-winning drug data help you?
Learn more about Medi-Span